Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process

Colloids and Surfaces B: Biointerfaces

Volumn 100, Issue , 2012, Pages 84-89

  Fangueiro, Joana F ^a   Andreani, Tatiana ^a,b,c   Egea, Maria A ^d   Garcia, Maria L ^d   Souto, Selma B ^e   Souto, Eliana B ^a,f  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF BARCELONA   (Spain)

^e University of Porto   (Portugal)

^f Centre of Genomics and Biotechnology   (Portugal)

Author keywords

Factorial design; Hydrophilic drugs; Lipid nanocarriers; Multiple emulsion; Solid lipid nanoparticles

Indexed keywords

FACTORIAL DESIGN; HYDROPHILIC DRUGS; MULTIPLE EMULSIONS; NANOCARRIERS; SOLID LIPID NANOPARTICLE (SLN);

BIOMOLECULES; EMULSIFICATION; EMULSIONS; NANOPARTICLES; OPTIMIZATION; PROTEINS; ZETA POTENTIAL;

HYDROPHILICITY;

ALGINIC ACID; LIPID; LIPID NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BIOTECHNOLOGY; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DROPLET SIZE; EMULSION; FACTORIAL DESIGN; HYDROPHILICITY; LIPOPHILICITY; PARTICLE SIZE; PH; POLYDIVERSITY INDEX; PRIORITY JOURNAL; SOLID; ZETA POTENTIAL;

ALGINATES; ALGORITHMS; DRUG CARRIERS; EMULSIFYING AGENTS; EMULSIONS; EXCIPIENTS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPIDS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; RESEARCH DESIGN; WATER;

EID: 84863226116     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.04.014     Document Type: Article

References (34)

1. Joshi M.D., Muller R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 2009, 71:161-172.
2. Severino P., Andreani T., Macedo A., Fangueiro J.F., Silva A.M., Santana M.H., Souto E.B. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J. Drug. Deliv. 2012, 10.1155/2012/750891.
3. Souto E.B., Muller R.H. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb. Exp. Pharmacol. 2010, 197:115-141.
4. Souto E.B., Muller R.H. Solid lipid nanoparticles and nanostructures lipid carriers - lipid nanoparticles for medicals and pharmaceuticals. Encyc. Nanosci. Nanotechnol. 2011, 23:313-328.
5. Fangueiro J.F., Gonzalez-Mira E., Martins-Lopes P., Egea M.A., Garcia M.L., Souto S.B., Souto E.B. A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing. Pharm. Dev. Technol. 2011, 10.3109/10837450.2011.591804.
6. Almeida A.J., Souto E.B. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliv. Rev. 2007, 59:478-490.
7. Martins S., Ferreira D.C., Souto E.B. Lipid nano particle-based systems for delivery of biomacromolecule therapeutics. Delivery Technologies for Biopharmaceuticals 2009, John Wiley & Sons, Ltd., pp. 129-148.
8. Gallarate M., Trotta M., Battaglia L., Chirio D. Preparation of solid lipid nanoparticles from w/o/w emulsions: preliminary studies on insulin encapsulation. J. Microencapsul. 2009, 26:394-402.
9. Wiechers J., Souto E.B. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as novel delivery systems for cosmetic actives. Part I. Cosm. Toiletries 2010, 10:22-30.
10. Souto E.B., Teeranachaideekul V., Boonme P., Muller R.H., Junyapraset V.B. Lipid-based nanocarriers for cutaneous administration of pharmaceutics. Encyc. Nanosci. Nanotechnol. 2011, 15:479-491.
11. Wissing S.A., Kayser O., Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 2004, 56:1257-1272.
12. Attama A.A. SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat. Drug Deliv. Formul. 2011, 5:178-187.
13. Heike B. Structural properties of solid lipid based colloidal drug delivery systems. Curr. Opin. Colloid Interface Sci. 2011, 16:405-411.
14. Souto E.B., Doktorovova S. Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery, Chapter 6. Methods Enzymol. 2009, 464:105-129.
15. Carlotti M.E., Gallarate M., Sapino S., Ugazio E. W/O/W multiple emulsions for dermatological and cosmetic use, obtained with ethylene oxide free emulsifiers. J. Dispers. Sci. Technol. 2005, 26:183-192.
16. Schmidts T., Dobler D., Nissing C., Runkel F. Influence of hydrophilic surfactants on the properties of multiple w/o/w emulsions. J. Colloid Interface Sci. 2009, 338:184-192.
17. Garcia-Fuentes M., Torres D., Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B 2003, 27:159-168.
18. Jiao J., Burgess D. Rheology and stability of water-in-oil-in-water multiple emulsions containing Span 83 and Tween 80. AAPS PharmSci. 2003, 5:1-12.
19. Morais J.M., Santos O.D.H., Nunes J.R.L., Zanatta C.F., Rocha-Filho P.A. W/O/W multiple emulsions obtained by one-step emulsification method and evaluation of the involved variables. J. Dispers. Sci. Technol. 2008, 29:63-69.
20. Gonzalez-Mira E., Egea M.A., Souto E.B., Calpena A.C., Garcia M.L. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2010, 22:045101.
21. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J. Control. Release 2006, 114:1-14.
22. Liew C.V., Chan L.W., Ching A.L., Heng P.W.S. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm. 2006, 309:25-37.
23. Wittaya-areekul S., Kruenate J., Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int. J. Pharm. 2006, 312:113-118.
24. Borges O., Cordeiro-da-Silva A., Romeijn S.G., Amidi M., de Sousa A., Borchard G., Junginger H.E. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J. Control. Release 2006, 114:348-358.
25. Zhang Y., Wei W., Lv P., Wang L., Ma G. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur. J. Pharm. Biopharm. 2011, 77:11-19.
26. Schubert M.A., Muller-Goymann C.C. Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters. Eur. J. Pharm. Biopharm. 2003, 55:125-131.
27. Harms M., Muller-Goymann C.C. Solid lipid nanoparticles for drug delivery. J. Drug Del. Sci. Technol. 2011, 21:89-99.
28. Annick L. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev. 2005, 57(11):1595-1639.
29. Cohen S., Lobel E., Trevgoda A., Peled Y. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J. Control. Release 1997, 44:201-208.
30. Sirkiä T., Salonen H., Veski P., Jürjenson H., Marvola M. Biopharmaceutical evaluation of new prolonged-release press-coated ibuprofen tablets containing sodium alginate to adjust drug release. Int. J. Pharm. 1994, 107:179-187.
31. Leonard M., De Boisseson M.R., Hubert P., Dalençon F., Dellacherie E. Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J. Control. Release 2004, 98:395-405.
32. Trinquand C., Romanet J.-P., Nordmann J.-P., Allaire C. Efficacité et tolérance du cartéolol 1% à libération prolongée une fois par jour: Etude randomisée en double insu. J. Français d'Ophtalmologie. 2003, 26:131-136.
33. Zimmermann E., Müller R.H. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN™) dispersions in artificial gastrointestinal media. Eur. J. Pharm. Biopharm. 2001, 52:203-210.
34. Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J. Microencapsulation 1999, 2:205-213.